Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Sep. 30, 2020
Current Assets:
Cash and cash equivalents	$ 35,754	$ 30,785
Available-for-sale securities	18,120	30,313
Accounts receivable, net of allowances of $123 and $130 as of December 31, 2020 and September 30, 2020, respectively	8,065	7,675
Contract assets — royalties and license fees	6,566	6,108
Inventories, net	6,261	5,966
Income tax receivable	2,544	2,391
Prepaids and other	3,553	3,370
Total Current Assets	80,863	86,608
Property and equipment, net	30,346	30,103
Deferred income taxes	7,004	7,315
Intangible assets, net	12,945	13,283
Goodwill	27,864	27,185
Other assets	4,534	4,269
Total Assets	163,556	168,763
Current Liabilities:
Accounts payable	863	1,515
Accrued liabilities:
Compensation	2,944	6,630
Accrued other	4,086	5,547
Deferred revenue	4,553	5,200
Total Current Liabilities	12,446	18,892
Deferred revenue, less current portion	10,073	10,796
Other long-term liabilities	7,630	8,020
Total Liabilities	30,149	37,708
Commitments and Contingencies (Note 17)
Stockholders’ Equity:
Series A Preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000 shares authorized; 13,739 and 13,672 shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively	687	684
Additional paid-in capital	16,160	15,369
Accumulated other comprehensive income	5,006	3,174
Retained earnings	111,554	111,828
Total Stockholders’ Equity	133,407	131,055
Total Liabilities and Stockholders’ Equity	$ 163,556	$ 168,763